• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:戴丽丽,苏志桂,张灿.纳米药物递送系统靶向动脉粥样硬化斑块的研究进展[J].药学研究,2017,36(8):471-476[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3412次   下载 3651次 本文二维码信息
码上扫一扫!
纳米药物递送系统靶向动脉粥样硬化斑块的研究进展
戴丽丽,苏志桂,张灿
字体:加大+|默认|缩小-
(中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009)
摘要:
心血管疾病是全球死亡率最高的疾病,而动脉粥样硬化是心血管疾病主要诱因。鉴于常规的给药方式,进入斑块的药物浓度很低,难以实现直接针对斑块的有效治疗策略。纳米药物递送系统在靶向斑块、斑块局部释放药物和提高斑块内药物有效浓度等方面具有显著优势,为动脉粥样硬化的诊断、治疗和疗效评估等提供了切实可行的方法和技术平台。本文从靶向递送策略的角度对近年来针对动脉粥样硬化斑块的纳米药物递送系统进行综述,为纳米药物递送系统应用于动脉粥样硬化诊疗的设计和构建提供参考。
关键词:  动脉粥样硬化  纳米药物递送系统  靶向治疗  斑块
DOI:10.13506/j.cnki.jpr.2017.08.011
基金项目:国家自然科学基金(No.81503006、BK20150698、81473153)
Research progress on nanomedicine delivery systems in targeting atherosclerosis
DAI Lili,SU Zhigui,ZHANG Can
(State Key Laboratory of active ingredients and efficacy of natural drugs, China Pharmaceutical University,Nanjing 210009,China)
Abstract:
Cardiovascular disease occupies the highest mortality rates in the world.Atherosclerosis (AS) is the major cause of cardiovascular disease.For traditional administration method,the concentration of drug in in the AS plaque is low,which would be difficult to implement the curative effect in plaque.As known to everyone, compared to traditional small molecule drugs,nanomedicine delivery systems possess the capacities of targeting AS plaque,triggering drug release and elevating the effective concentration of drugs in AS plaque,which would provide a potential platform and technology for diagnosis,treatment,and integration of diagnosis and treatment of AS therapy.In this paper,recently nanomedicine delivery systems for targeting AS plaque were reviewed in the angle of targeting strategy,which was aimed to provide reference to reasonable design and construct novel nanomedicine delivery systems.
Key words:  Atherosclerosis  Nanomedicine delivery systems  Targeted therapy  Plaque
今日访问量:2433    总访问量:55338849
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司